Biotech | January 20, 2026
IDT and Ansa Biotechnologies join forces to push limits of DNA synthesis
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
The collaboration aims to accelerate the delivery of challenging DNA motifs with speed, precision, and reliability
BioNTech is positioning 2026 as a defining year in its transition toward a multi-product oncology company
BFF provides bookable fermentation upscaling capacity, process expertise, and quality procedures for pilot campaigns, generating decision-grade data without companies needing to build their own facilities
Preclinical studies show that 4P004 modulates multiple biological markers across the joint, potentially slowing structural damage while improving function
The privately held biotech brings a first-in-class oncology program focused on small molecule–targeted protein degradation
Gland Pharma receives approval for Olopatadine Hydrochloride Ophthalmic Solution USP, 0.7% (OTC)
Kelun-Biotech and Crescent Biopharma forged a collaboration covering SKB105/CR-003 and SKB118, a PD-1 x VEGF bispecific antibody also known as CR-001
GlideTech materials are available in several standard base resins and offer customization options for specific applications
Sovaaka offers a deeply personalised diagnostics-led wellness experience that goes beyond routine health checks
Leaders from science, policy, industry, and investment came together in New Delhi to examine how alignment across the biotechnology value chain can turn innovation into outcomes at scale
Subscribe To Our Newsletter & Stay Updated
